Ascletis Pharma Inc. (HKG:1672)

Ascletis Pharma Revenue

Ascletis Pharma had revenue of 947.00K CNY in the twelve months ending June 30, 2026, down -59.94% year-over-year. In the year 2025, Ascletis Pharma had annual revenue of 2.03M with 58.07% growth. That makes Ascletis Pharma the 45,779th largest company in the world by revenue and 2,601st in Hong Kong.

• Revenue (ttm): 947.00K CNY
• Revenue Growth: -59.94%
• P/S Ratio: 5,536.29
• Revenue / Employee: 4.36K CNY
• Employees: 217
• Market Cap: 6.33B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Geography

Chart

• Hong Kong 1.62M 79.8%
• Other region 409.00K 20.2%

Fiscal year ended Dec 31, 2025 See the full Ascletis Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.03M	745.00K	58.07%
Dec 31, 2024	1.28M	-55.31M	-97.73%
Dec 31, 2023	56.60M	2.51M	4.63%
Dec 31, 2022	54.09M	-22.79M	-29.64%
Dec 31, 2021	76.88M	41.88M	119.64%

Data Source: S&P Global Market Intelligence Last updated: Sep 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 17, 2026

Data Sources Report a data error